Both in Biotechnology
CRISPR Therapeutics AG vs Immunovant
Over the past year CRSP returned −19.6% and IMVT returned +18.2%; their daily moves had a correlation of 0.41.
CRSP −19.6% IMVT +18.2%Growth of $1, one year, split-adjusted
| Metric | CRSP | IMVT |
|---|---|---|
| Price | $51.42 | $29.17 |
| Market cap | $4.97B | $6.03B |
| Today | −5.23% | −1.59% |
| 1 month | −7.3% | −13.3% |
| 6 months | −0.4% | +7.6% |
| Year to date | −1.9% | +14.8% |
| 1 year | −17.8% | +34.7% |
| Revenue growth (YoY) | +1041.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −895.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 371.3× | — |
| Net cash | $1.78B | $797.8M |
| Dividend yield | — | — |
| Volatility (60d) | 53.4% | 36.8% |
| Short % of float | 21.0% | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).